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Case Report 
Unusual Presentation of Abdominal Castleman’s
Disease
W.L.E. Chuwa, K.L. Chuah1 and H.S. Ong, Departments of Surgery and 1Pathology, Singapore General Hospital,
Singapore.
Castleman’s disease is a rare lymphoproliferative disorder of uncertain origin. We report an unusual pres-
entation of Castleman’s disease in the transverse mesocolon that mimicked a vascular gastrointestinal
stromal tumour and review the literature surrounding this peculiar entity. [Asian J Surg 2006;29(3):153–6]
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Introduction
Castleman’s disease is a rare lymphoproliferative disorder
of uncertain origin. We report an unusual presentation of
Castleman’s disease in the transverse mesocolon that
mimicked a vascular gastrointestinal stromal tumour and
review the literature surrounding this peculiar entity.
Case report
A 28-year-old man presented with vague abdominal dis-
comfort and mechanical low back pain for about 2
months. Physical examination was unremarkable, labora-
tory data were within the normal limits and chest X-ray
was normal. Lumbosacral X-rays (Figure 1) revealed no
bony abnormalities but showed an amorphous opacity
between the transverse processes of L3 and L4 on the right
suggestive of retroperitoneal calcification. Computed
tomography (CT) scan (Figure 2) showed a well-defined
vascular soft tissue mass measuring 4 × 3.5 cm situated
inferior to the second part of the duodenum and adjacent
to the inferior vena cava. It bore a focus of calcification
that was surrounded by soft tissue of low density represen-
tative of necrosis. Oesophagogastroduodenoscopy merely
showed a subtle eccentric deformity at the junction of 
the second and third parts of the duodenum causing
extrinsic compression. With clinical features suspicious
of a duodenal gastrointestinal stromal tumour, surgical
excision was planned in view of its size and the patient’s
symptoms.
Intraoperatively, the tumour was found within the
transverse mesocolon and measured 5.5 × 3.5 × 3.5 cm. It
had a fleshy consistency suggestive of a lymphomatous
lymph node (Figure 3). A thorough exploration revealed
no intra-abdominal lymphadenopathy or any visceral
abnormalities. The tumour was closely related to the supe-
rior mesenteric artery (SMA) on its medial aspect with
multiple feeding vessels. It was meticulously dissected
with a gross margin of 1 cm. Feeding vessels were ligated
and divided without injuring the SMA or compromising
bowel viability. Histological examination demonstrated
typical features of hyaline vascular type of Castleman’s dis-
ease (Figure 4).  During the 1-year follow-up, the patient
was well with no evidence of recurrent disease.
Discussion
Castleman’s disease was first described in 1954 in 13 pa-
tients with giant mediastinal lymph nodes resembling thy-
moma.1 Since then, it has been referred to as angiofollicular
lymph node hyperplasia, giant lymph node hyperplasia,
lymphoid hamartoma, angiomatous lymphoid hamartoma,
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benign lymphoma or follicular lymphoreticuloma, only to
account for its uncertain aetiology. Theories including
chronic low grade inflammation, hamartomatous process,
an immunodeficient state and autoimmune process have
been proposed as likely pathogenetic mechanisms.2,3
Based on histological characteristics, Keller et al classi-
fied this disease into two variants: the hyaline vascular
type (HV) and the plasma cell (PC) type.3
The HV variant consists of small distinct vascular folli-
cles surrounded by palisading layers of small lymphocytes
with radially arranged capillaries penetrating the germi-
nal centres while the PC variant demonstrates larger lym-
phoid follicles and a markedly less vascular interfollicular
stroma where PCs predominate. The HV variant is by far
more common, comprising 91% of reported cases and
largely runs a benign course, resulting in symptoms in
only 3% of cases,4 which are largely discovered inciden-
tally, as in our case. In contrast, though less common, the
PC variant tends to be more clinically aggressive with sys-
temic manifestations such as fever, anaemia, hypergam-
maglobulinaemia and an increase in acute phase proteins
in up to 50% of cases. Interleukin-6 (IL-6) is reported to
play a key role in these systemic features,2 with clinically
documented decrease in its levels and disappearance of
symptoms following surgical removal.
Though first reported occurring in the mediastinum,1
virtually all lymph node-bearing regions and even non-
nodal tissues may be involved.2,3 Its clinical presentations
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Soft tissue mass
Inferior vena cava
Figure 2. Computed tomography show the close proximity of the
soft tissue mass (with a calcified centre) to the inferior vena cava.
Transverse mesocolon
Vascular mass
Figure 3. Intraoperative findings of the vascular mass with mul-
tiple feeding vessels within the transverse mesocolon.
A B
Figure 1. Lumbosacral X-rays show an amor-
phous opacity (arrow) suggestive of retroperi-
toneal calcification.
can be either localized or multicentric. Localized disease
is usually asymptomatic and involves the mediastinum in
70% of cases. Isolated cases have been reported in the cen-
tral nervous system, orbit, neck, axilla, skeletal muscles,
the retroperitoneum, pancreas and the mesentery.2–4 In
particular, mesenteric disease is rare with only 22 cases
reported in the English literature to date. Of interest,
localized disease is predominantly of the HV type and
potentially curable by surgical resection. Though surgical
removal might not always be necessary for asymptomatic
Castleman’s disease, operative management is frequently
unavoidable since preoperative diagnosis is evasive.
In contrast, multicentric disease is clinically more aggres-
sive with systemic manifestations and potentially fatal infec-
tive complications. It has a tendency to involve the peripheral
lymph nodes and is predominantly of the PC variant. It
may run one of the four courses: relapse and remission,
stable and persistent, rapidly fatal or transformation into
malignant lymphoma. Systemic therapy in the form of
steroids and chemotherapeutic agents such as cyclophos-
phamide, doxorubicin and vincristine have been tried with
varying success rates, while administration of murine
anti-IL-6 antibody has been reported to produce transient
improvement in symptoms and laboratory values.5
Though definitive diagnosis necessitates histological
analysis, radiological features may be helpful. HV lesions
often demonstrate fine calcification that is evident even 
on plain X-rays, as in our case. On CT or magnetic reso-
nance imaging, lymphoid lesions, which are involved, typi-
cally demonstrate homogeneous contrast enhancement.
This distinguishes Castleman’s disease from other masses
such as thymomas or lymphomas, which generally show
no enhancement on CT scan.6 Being highly vascular
lesions, these masses characteristically show a prolonged
dense tumour “blush” in the capillary phase of angiog-
raphy. This can be used to delineate the hypertrophied
feeding vessels that supply these lesions. Preoperative
embolization has been advocated to facilitate surgical
excision and decrease intraoperative bleeding, but this is
not widely practiced.7
Complete surgical excision is the mainstay of treatment
and is virtually curative in all cases reported so far, with a
5-year survival rate approaching 100%.3,4 However, local
recurrence has been reported after subtotal or partial
resection. Radiation therapy has been used with varying
success in unresectable lesions.8
The appearance of associated malignant tumours 
has been occasionally reported and may be the result of 
a slow hyperplastic process, appearing as lymphomas in
the PC type9 and vascular tumours resembling Kaposi’s
sarcoma in the HV type.10 These have been reported to
develop as long as 8 years after the initial diagnosis, hence,
lifelong follow-up is recommended. As Castleman’s disease
remains a rare and poorly understood condition, there is
no existing best way to follow-up these patients. For cases
of localized HV type of Castleman’s disease similar to ours,
we propose 6–12 monthly physical examinations after sur-
gical excision with abdominal CT scan or ultrasound eval-
uation every 3–5 years or whenever symptoms arise.
References
1. Castleman B, Towne VW. Case records of the Massachussets
General Hospital, case 40011 (hyperplasia of mediastinal lymph
nodes). N Engl J Med 1954;250:26–30.
2. Castleman B, Iverson L, Menendez VP. Localised mediastinal
lymph node hyperplasia resembling thymoma. Cancer 1956;9:
822–30.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and
plasma-cell types of giant lymph node hyperplasia of the medi-
astinum and other locations. Cancer 1972;29:670–83.
4. D’Agay MF, Miclea JM, Clauvel JP. Castleman’s disease: a well
defined histological pattern for a widely divergent clinical spec-
trum. Nouv Rev Fr Hematol 1989;31:145–8.
5. Beck J, Hsu SM, Wijdenes J. Brief report: alleviation of sys-
temic manifestations of Castleman’s disease by monoclonal
anti-interleukin-6 antibody. N Engl J Med 1994;330:602–5.
6. Ferreiros J, Gomez Leon N, Mata MI, et al. Computed tomogra-
phy in abdominal Castleman’s disease. J Comput Assist Tomogr
1989;13:433–6.
■ MESENTERIC CASTLEMAN’S DISEASE ■
ASIAN JOURNAL OF SURGERY VOL 29 • NO 3 • JULY 2006 155
Figure 4. Blood vessels with hyalinized walls traverse the centre of
a germinal centre, a typical feature of hyaline vascular Castleman’s
disease.
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